Skip to main content
. 2015 Feb 3;187(2):E74–E81. doi: 10.1503/cmaj.140900

Table 1:

Baseline characteristics of the eligibility groups in the study cohort

Characteristic Program eligibility group; % of eligibility group*
Ineligible (n = 131 781) Eligible (n = 128 712)
Sociodemographic
Age, yr, mean ± SD 13.17 ± 0.28 13.17 ± 0.28
Birth quarter
 Jan.–Mar. 24.3 24.2
 Apr.–June 26.1 26.1
 July–Sept. 25.7 25.8
 Oct.–Dec. 23.9 23.9
Residency
 Urban 85.3 85.8
 Rural 14.0 13.5
 Missing 0.7 0.6
Income quintile
 1 (lowest) 16.6 15.0
 2 18.4 17.8
 3 20.6 21.1
 4 22.0 23.1
 5 (highest) 21.4 22.1
 Missing 1.0 0.9
Vaccination history§
 Measles–mumps–rubella 97.9 98.2
 Diphtheria, tetanus and pertussis 98.0 98.3
 Hepatitis B 84.1 82.0
 All 3 vaccines 83.0 81.1
Health services use**††
Hospital admission
 0 98.0 98.2
 ≥ 1 2.0 1.8
 LOS, d, mean ± SD 7.4 ± 15.6 8.0 ± 18.2
Same-day surgery
 0 97.7 97.8
 ≥ 1 2.4 2.2
Emergency department visits
 0 70.7 71.1
 1 18.1 17.8
 ≥ 2 11.2 11.1
Outpatient visits
 0 or 1 22.6 22.8
 2–5 27.4 26.9
 6–12 25.1 24.5
 ≥ 13 25.0 25.8
Medical history
Cancer** 0.7 0.7
Mental health diagnosis** 9.5 9.7
Sexual health indicators**‡‡ 0.7 0.7
Down syndrome 0.5 0.5
Congenital malformations 12.4 11.8
Intellectual disability§ 0.7 0.7

Note: LOS = length of stay, SD = standard deviation.

*

Except where indicated otherwise.

At cohort entry.

Because of missing or inaccurate postal code.

§

Between birth and cohort entry.

At least 1 dose.

**

In the 2 years before cohort entry.

††

Categories determined on the basis of the frequency distribution.

‡‡

Composite of sexually transmitted infections, cervical dysplasia, Papanicolaou smear and pregnancy.